Cardiac Events in Patients with Acute Myeloid Leukemia Treated with Venetoclax in Combination with Hypomethylating Agents

被引：3
|
作者：
Johnson, Isla M. [1 ]
Bezerra, Evandro D. [2 ]
Farrukh, Faiqa [3 ]
McCullough, Kristen [4 ]
Al-Kali, Aref [2 ]
Alkhateeb, Hassan B. [2 ]
Begna, Kebede H. [2 ]
Litzow, Mark R. [2 ]
Hogan, William J. [2 ]
Shah, Mithun V. [3 ]
Patnaik, Mrinal M. [2 ]
Tefferi, Ayalew [2 ]
Gangat, Naseema [2 ]
机构：
[1] Mayo Clin, Dept Med, Rochester, MN USA
[2] Mayo Clin, Div Hematol, Rochester, MN USA
[3] Mayo Clin, Rochester, MN USA
[4] Mayo Clin, Div Pharmacol, Rochester, MN USA
来源：
BLOOD | 2021年 / 138卷
关键词：
D O I：
10.1182/blood-2021-149704
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
219
引用
收藏
页数：4
相关论文
共 50 条
  • [1] Cardiac events in patients with acute myeloid leukemia treated with venetoclax combined with hypomethylating agents
    Johnson, Isla M.
    Bezerra, Evandro D.
    Farrukh, Faiqa
    McCullough, Kristen
    Al-Kali, Aref
    Alkhateeb, Hassan B.
    Begna, Kebede
    Litzow, Mark R.
    Hogan, William J.
    Shah, Mithun Vinod
    Patnaik, Mrinal M.
    Tefferi, Ayalew
    Gangat, Naseema
    [J]. BLOOD ADVANCES, 2022, 6 (17) : 5227 - 5231
  • [2] Hypomethylating Agents and Venetoclax in Acute Myeloid Leukemia
    DiNardo, Courtney D.
    [J]. CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2021, 19 (02) : 82 - 83
  • [3] Response rates in acute myeloid leukemia patients treated with attenuated durations of venetoclax in combination with hypomethylating agents.
    Blanding, Dena
    Jonathan, Bakos Keegan
    Rangel, Christopher Andrew
    Pasyar, Sarah
    Hill, Elizabeth Goodwin
    Davis, James
    Hess, Brian T.
    Baratam, Praneeth
    Greenwell, Irl Brian
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [4] Prognostic risk signature in patients with acute myeloid leukemia treated with hypomethylating agents and venetoclax
    Bataller, Alex
    Bazinet, Alexandre
    Dinardo, Courtney D.
    Maiti, Abhishek
    Borthakur, Gautam
    Daver, Naval G.
    Short, Nicholas J.
    Jabbour, Elias J.
    Issa, Ghayas C.
    Pemmaraju, Naveen
    Yilmaz, Musa
    Montalban-Bravo, Guillermo
    Takahashi, Koichi
    Loghavi, Sanam
    Garcia-Manero, Guillermo
    Ravandi, Farhad
    Kantarjian, Hagop M.
    Kadia, Tapan M.
    [J]. BLOOD ADVANCES, 2024, 8 (04) : 927 - 935
  • [5] Impact of monocytic differentiation on acute myeloid leukemia patients treated with venetoclax and hypomethylating agents
    Jin, Dian
    He, Jingsong
    Chen, Haoguang
    Wu, Wenjun
    Han, Xiaoyan
    Le, Jing
    Shu, Wenxiu
    Yang, Qianqian
    Pei, Shanshan
    Cai, Zhen
    He, Donghua
    [J]. CANCER MEDICINE, 2024, 13 (14):
  • [6] Hypomethylating Agents in Combination with Venetoclax As a Bridge to Allogeneic Transplant in Acute Myeloid Leukemia
    Kennedy, Vanessa E.
    Hui, Gavin
    Gaut, Daria
    Mittal, Varun
    Oliai, Caspian
    Muffly, Lori S.
    Logan, Aaron C.
    Mannis, Gabriel N.
    [J]. BLOOD, 2020, 136
  • [7] Efficacy of the combination of venetoclax and hypomethylating agents in relapsed/refractory acute myeloid leukemia
    Aldoss, Ibrahim
    Yang, Dongyun
    Aribi, Ahmed
    Ali, Haris
    Sandhu, Karamjeet
    Al Malki, Monzr M.
    Mei, Matthew
    Salhotra, Amandeep
    Khaled, Samer
    Nakamura, Ryotaro
    Snyder, David
    O'Donnell, Margaret
    Stein, Anthony S.
    Forman, Stephen J.
    Marcucci, Guido
    Pullarkat, Vinod
    [J]. HAEMATOLOGICA, 2018, 103 (09) : E404 - E407
  • [8] Resistance to venetoclax and hypomethylating agents in acute myeloid leukemia
    Saliba, Antoine N.
    John, August J.
    Kaufmann, Scott H.
    [J]. CANCER DRUG RESISTANCE, 2021, 4 (01) : 125 - 142
  • [9] Invasive fungal infections in acute myeloid leukemia treated with venetoclax and hypomethylating agents
    Aldoss, Ibrahim
    Dadwal, Sanjeet
    Zhang, Jianying
    Tegtmeier, Bernard
    Mei, Matthew
    Arslan, Shukaib
    Al Malki, Monzr M.
    Salhotra, Amandeep
    Ali, Haris
    Aribi, Ahmed
    Sandhu, Karamjeet
    Khaled, Samer
    Snyder, David
    Nakamura, Ryotaro
    Stein, Anthony S.
    Forman, Stephen J.
    Marcucci, Guido
    Pullarkat, Vinod
    [J]. BLOOD ADVANCES, 2019, 3 (23) : 4043 - 4049
  • [10] Efficacy of hypomethylating agents and Venetoclax in unfit patients with acute myeloid leukemia
    Rieger, M.
    Manz, M. G.
    Muller, R.
    Theocharides, A. P. A.
    Schwotzer, R.
    [J]. SWISS MEDICAL WEEKLY, 2020, : 17S - 17S
12345